PCR and Western Blot suggested METTL3 expression was upregulated in the fatty liver and in steatosis HepG2 cells (Fig. 2A, B), indicating the potential role of METTL3 in NAFLD. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatotic liver disease.